Look for:

Products

GETINGE AB SER. B


ISIN:
SE0000202624
WKN:
4385208

2024/03/28 08:16:30
Price
18.675 EUR
Difference 2.86% (0.52)

General attributes

ISINSE0000202624
SymbolGETI B
ExchangeBerlin
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)4,808 EUR
BenchmarkOMX STOCKHOLM 30 INDEX

Market data

Bid (Bid size)18.565 EUR (600)
Ask (Ask size)18.59 EUR (600)
Open18.675 EUR
High18.675 EUR
Low18.675 EUR
Close (prev. day)18.155 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Futures and Options

Related Futures36
Related Options-

PDF Downloads

Company report: GETINGE AB SER. BPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2024/03/13 en Global Equity Ratings PDF Download
2024/02/22 en Global Equity Ratings PDF Download
2024/02/14 en Global Equity Ratings PDF Download
2024/01/23 en Global Equity Ratings PDF Download
2023/12/21 en Global Equity Ratings PDF Download


2024/03/28 08:16:30
Price
18.675 EUR
Difference 2.86% (0.52)

General attributes

ISINSE0000202624
SymbolGETI B
ExchangeBerlin
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)4,808 EUR
BenchmarkOMX STOCKHOLM 30 INDEX

Market data

Bid (Bid size)18.565 EUR (600)
Ask (Ask size)18.59 EUR (600)
Open18.675 EUR
High18.675 EUR
Low18.675 EUR
Close (prev. day)18.155 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Performance and Risk

6m1Y3Y
Perf (%)+9.70%-16.41%-22.55%
Perf (abs.)+1.61-3.57-5.29
Beta1.011.150.94
Volatility33.6136.3739.06
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)18.146 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)18.263 EUR (0)
Ø price 100 days | Ø volume 100 days (pcs.)18.975 EUR (0)
Ø price 250 days | Ø volume 250 days (pcs.)18.561 EUR (1)
YTD High | date20.800 EUR (2024/01/03)
YTD Low | date16.885 EUR (2024/02/06)
52 Weeks High | date23.550 EUR (2023/04/25)
52 Weeks Low | date14.860 EUR (2023/07/07)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/03/2809:3018.68 EUR0.001
Stuttgart2024/03/2808:1018.825 EUR0.001
Nasdaq Stockholm2024/03/2809:57214.40 SEK11.43343
Munich2024/03/2808:1618.675 EUR0.001
London Stock Exchange European Trade Reporting2024/03/2809:00217.15 SEK0.001
Hanover2024/03/2808:1018.865 EUR0.001
Frankfurt2024/03/2808:1118.675 EUR0.001
FINRA other OTC Issues2024/02/2921:3519.56 USD0.014
Duesseldorf2024/03/2809:3118.60 EUR0.002
Berlin2024/03/2808:1618.675 EUR0.001
BX Swiss2024/02/2718:0017.801 CHF0.011

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=140686&ID_TYPE_IMAGE_LOGO=2

Contact Details

GETINGE AB
- -
Lindholmspiren 7A - 417 56 Gothenburg
Telefon: +46-10-335-0000
Fax: +46-10-335-5640
E-mail: info@getinge.com

PDF Downloads

Company report: GETINGE AB SER. BPDF Download

Company Profile

Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It offers products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. The firm operates through the following segments: Acute Care Therapies, Life Science and Surgical Workflows. The Acute Care Therapies segment offers solutions for life support in acute health conditions. The Life Science segment offers a comprehensive range of equipment, technical expertise and consultation to prevent contamination in biopharmaceutical production, biomedical research, medical device manufacturing and laboratory applications. The Surgical Workflows segment offers products and services for efficient disinfection and sterilization of instruments used in operations, operating tables and other high-quality hardware for operating rooms and advanced IT systems for efficient and secure hospital workflows. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden.

Members of Management Board

Mattias PerjosChairman of Managing Board
Anna RombergMember of Executive Committee
Carsten BleckerMember of Executive Committee
Harald CastlerMember of Executive Committee
Jeanette Hedén CarlssonMember of Executive Committee
Jens ViebkeMember of Executive Committee
Lars SandströmMember of Executive Committee
Lena HagmanMember of Executive Committee
Magnus LundbäckMember of Executive Committee
Stéphane Le RoyMember of Executive Committee

Board of directors

Johan MalmquistChairman of Supervisory Board
Barbro FridénMember of Supervisory Board
Carl Reinhold Adolf BennetMember of Supervisory Board
Kristian SamuelssonMember of Supervisory Board
Cecilia Margaretha Daun-WennborgMember of Supervisory Board
Dan FrohmMember of Supervisory Board
Eva Christina Malin PerssonMember of Supervisory Board
Fredrik BrattbornMember of Supervisory Board
Frida GustafssonMember of Supervisory Board
Johan ByggeMember of Supervisory Board
Pontus KallénMember of Supervisory Board
Åke LarssonMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.